A cautious attitude to the adoption of innovative technologies has emerged as a direct result of the growing and stringent regulatory structure that exists within the industry.
However, in recent years, the pharmaceutical industry has seen a decline in R&D productivity, an increase in costs, difficulties with compliance and non-adherence, the expiration of patents, and an evolution in the expectations of stakeholders. This is what is driving the industry to look to IoT (Internet of Things) and other technologies for a solution.
While some early adopters have already begun researching IoT to allow end-to-end digital integration across manufacturing facilities, supply chains, delivery routes, clinical trials, R&D, and a wide variety of other fields, many others are still unsure of how to begin or what steps to take.
Join us in May to learn how to develop and successfully implement a strategy for the internet of things (IoT).
